Peptide Therapeutics Market Trends PowerPoint PPT Presentations

Global Market Insights recently added a detailed market research study focused on the Global Peptide Therapeutics Market across the global, regional and country level. The report provides 360° analysis of Peptide Therapeutics Market from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Peptide Therapeutics Market and estimates the future trend of industry on the basis of this detailed study.

The global peptide therapeutics market size is expected to grow from $34.12 billion in 2021 to $37.13 billion in 2022 at a compound annual growth rate (CAGR) of 8.8%.

Peptide therapeutics market is expected to grow over the forecast period owing to the increasing prevalence of cancer and other various metabolic diseases.

Peptide Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision.

Read here the latest updates on the Peptide Therapeutics Market Analysis published by CMI team

The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.2% from 2020 to 2027.

According to the latest research report by IMARC Group, The global peptide therapeutics market size reached US$ 39.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 66.1 Billion by 2028, exhibiting a growth rate (CAGR) of 9% during 2023-2028. More Info:- https://www.imarcgroup.com/peptide-therapeutics-market

According to the latest research report by IMARC Group, The global peptide therapeutics market reached a value of US$ 35.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2027, exhibiting a CAGR of 9.42% during 2022-2027. More Info:- https://www.imarcgroup.com/peptide-therapeutics-market

The COVID-19 epidemic is predicted to have a moderately positive impact on the growth of the global peptide therapeutics industry. Many peptide drugs were under clinical trials for the COVID_19 treatment. Furthermore, it is anticipated that the strong government support for the use of peptides in the creation of the COVID-19 vaccine would create a variety of chances for peptide adoption, ultimately accelerating the expansion of the market for peptide treatments. As of May 2020, 15 synthetic peptides were being used to treat ARDS and other respiratory conditions brought on by the SARS-Cov-2 virus, bringing the total number of peptide drugs available for the treatment of COVID-19 to 21. Know More- https://www.alliedmarketresearch.com/peptide-therapeutics-market-A11226

TBRC global peptide therapeutics market report includes generic, branded, parenteral, mucosal, oral, transdermal, cancer, cardiovascular diseases, central nervous systems

According to the latest research report by IMARC Group, The global oat milk market reached a value of US$ 495.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,062.6 Million by 2027, exhibiting a CAGR of 13.72% during 2022-2027. More Info:- https://www.imarcgroup.com/oat-milk-market

The global biosimilar therapeutic peptides market size is expected to grow from $0.93 billion in 2021 to $1.21 billion in 2022 at a compound annual growth rate (CAGR) of 30.3%.

A new report on Global Oral Proteins and Peptides Industry 2016 Market Research Report seen on DecisionDatabases.com analyses the complete market. The industry sales & production volumes, industry’s trends are all discussed,explained and analysed.

According to Goldstein Research, “Medical industry is struggling to provide better cure for deadly and unknown origin diseases. Thrive for effective drugs are attracting the pharmaceutical industry to opt for advanced technologies. Anti-microbial peptides acts directly on microbial pathogens and have potential to fight against the unexpected rise of resistant organisms. Anti-microbial peptides market is expected to get hot capital investment backed by emergence of new antibiotics in therapeutics in the near future.”

According to Goldstein Research, “Medical industry is struggling to provide better cure for deadly and unknown origin diseases. Thrive for effective drugs are attracting the pharmaceutical industry to opt for advanced technologies. Anti-microbial peptides acts directly on microbial pathogens and have potential to fight against the unexpected rise of resistant organisms. Anti-microbial peptides market is expected to get hot capital investment backed by emergence of new antibiotics in therapeutics in the near future.”

The report on Biosimilar Market by product (human growth hormones, monoclonal antibodies, insulin, peptides, erythropoietin and others), application, (oncology, chronic and autoimmune diseases, growth hormone deficiency, infectious diseases and others) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Biosimilar Market is projected to grow at a CAGR between 25.0% to 26.0% in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The report on Anti-Obesity Prescription Drugs Market by drug class (orlistat, phentermine and topiramate, bupropion and naltrexone, lorcaserin, liraglutide), distribution channel (retail pharmacy, hospital pharmacy and online pharmacy), age group (pediatric and adult) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Anti-Obesity Prescription Drugs Market is projected to grow at a CAGR of 4.97% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

Peptide Based Cancer Therapeutics

Peptide synthesis is the process utilized for the production of peptides that are commonly known as peptide bonds and characterized as having multiple amino acids linked with amide bonds.

Global non-therapeutic biomolecules market size is expected at $41.26 Bn by 2027 at a growth rate of 10.3% and outlook by The Business Research Company.

According to the latest research report by IMARC Group, The United States migraine drugs market size is projected to exhibit a growth rate (CAGR) of 15.95% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-migraine-drugs-market

The driving forces behind industry growth and innovation include technological advancements, consumer awareness, regulatory changes, and market competition. Companies invest in research and development to create differentiated products, streamline manufacturing processes, and comply with evolving regulatory standards. Innovation hubs, industry partnerships, and investment in talent foster a culture of creativity and entrepreneurship driving continuous improvement and market expansion.

Biosimilar therapeutic peptides refer to a peptide drug that is used in place of or in addition to peptide hormones when endogenous levels tend to decline. Therapeutic peptides that are biosimilar have applications in the treatment of cancer, metabolic, pulmonary, cardiovascular, and other illnesses.

Read here the latest updates on the GLYCOBIOLOGY MARKET ANALYSIS published by CMI team.

Endogenous Peptide Substances Market

A new report on Global Oral Peptides Industry 2016 Market Research Report seen on DecisionDatabases.com analyses the complete market. The industry sales & production volumes, industry’s trends are all discussed,explained and analysed.

The report Global Oral Peptides Consumption 2016 Market Research Report covers the whole industry outlook with value chain analysis, DRO's, production and sales volumes and figures.

The report estimates the market size for 2013 and provides a forecast until 2020, and covers disease epidemiology, treatment algorithms, and treatment use patterns. For More Details: http://goo.gl/cSK8ZN

In 2022, the global revenue generated by the proteomics market reached approximately US$ 30.8 billion, and it is anticipated to exhibit a robust compound annual growth rate (CAGR) of 17.6%, projecting a valuation of US$ 181.5 billion by the conclusion of 2033. According to the evaluation conducted by Persistence Market Research, the reagents and kits segment is poised to dominate with the highest market value, reaching US$ 18.4 billion by 2023. Contributing to around 6.0% of the total revenue in the global omics market, valued at approximately US$ 514.3 billion by the close of 2022, sales in the proteomics market demonstrate a substantial presence. Over the past eight years, from 2014 to 2022, the global proteomics market has exhibited a historic CAGR of 15.5%.

Type 2 diabetes is a chronic condition, which arises due to either the inability of the body to produce enough insulin or insulin resistance, or both. Insulin is a peptide hormone produced by the Islets of Langerhans (pancreatic cells). It is produced in an immature form called preproinsulin, which is proteolytically cleaved to obtain proinsulin and then insulin. Type 2 diabetes nearly accounts for 90-95 percent of the total diabetic cases. Type 2 diabetes is usually diagnosed in middle-aged and older people; however, it can occur even during childhood. Type 2 diabetes was also known as adult-onset diabetes or non-insulin-dependent diabetes. Read more details at: http://www.bigmarketresearch.com/global-type-2-diabetes-therapeutics-2015-2019-market

Major players in the biosimilar therapeutic peptides market are Eli Lilly, Sanofi, Takeda Pharmaceuticals, Teva Pharmaceuticals, Pfizer Inc.,

The research study on Global Oral Proteins and Peptides Consumption 2016 Market Research Report by DecisionDatabases.com analyses the complete value chain of the Industry.

The Biosimilar Therapeutic Peptides Market is anticipated to reach USD 1.72 billion by 2023, according to a new research published by The Business Research Company. https://bit.ly/3ctwLAu

Type 2 diabetes is a chronic condition, which arises due to either the inability of the body to produce enough insulin or insulin resistance, or both. Insulin is a peptide hormone produced by the Islets of Langerhans (pancreatic cells). It is produced in an immature form called preproinsulin, which is proteolytically cleaved to obtain proinsulin and then insulin. Type 2 diabetes nearly accounts for 90-95 percent of the total diabetic cases. Type 2 diabetes is usually diagnosed in middle-aged and older people; Read Complete Report Here @ http://www.researchbeam.com/global-type-2-diabetes-therapeutics-2015-2019-market Global Type 2 Diabetes Therapeutics market to grow at a CAGR of 7.15 percent over the period 2014-2019. Enquire @ http://www.researchbeam.com/global-type-2-diabetes-therapeutics-2015-2019-market/enquire-about-report

Type 2 diabetes is a chronic condition, which arises due to either the inability of the body to produce enough insulin or insulin resistance, or both. Insulin is a peptide hormone produced by the Islets of Langerhans (pancreatic cells). It is produced in an immature form called preproinsulin, which is proteolytically cleaved to obtain proinsulin and then insulin. Type 2 diabetes nearly accounts for 90-95 percent of the total diabetic cases. Type 2 diabetes is usually diagnosed in middle-aged and older people; Read Complete Report Here @ http://www.researchbeam.com/global-type-2-diabetes-therapeutics-2015-2019-market Global Type 2 Diabetes Therapeutics market to grow at a CAGR of 7.15 percent over the period 2014-2019. Enquire @ http://www.researchbeam.com/global-type-2-diabetes-therapeutics-2015-2019-market/enquire-about-report

The Business Research Company offers metastatic breast cancer treatment market research report 2023 with industry size, share, segments and market growth

The economic impact of cancer is substantial, both in terms of healthcare costs and lost productivity. Peptide cancer vaccines offer cost-effective treatment options compared to traditional therapies like chemotherapy or radiation. - Social: Rising awareness about cancer prevention and treatment options has led to increased demand for innovative therapies such as peptide cancer vaccines. Additionally, the aging population and changing lifestyles contribute to the growing prevalence of cancer. - Technological: Advances in biotechnology and genomics have enabled the identification of specific cancer antigens and the development of personalized peptide cancer vaccines. Furthermore, advancements in vaccine delivery systems have improved the efficacy and safety of peptide cancer vaccines.

The rising prevalence of chronic diseases, including obesity and diabetes, is among the key factors driving the US insulin market. In addition to this, the escalating demand for insulin therapeutics is further propelling the market growth. Moreover, the growing requirement for biosimilar drugs, owing to their high efficiency and cost-effectiveness, is acting as another significant growth-inducing factor.

The major players covered in the global oral biologics & biosimilar drugs market are Novartis, Rani Therapeutics, Eli Lilly and Co., AstraZeneca plc, Novo Nordisk A/S.... @ @ https://bit.ly/3gz5Nve

The global biosimilar therapeutic peptides market is expected to grow from $0.76 billion in 2020 to $0.87 billion in 2021 at a compound annual growth rate (CAGR) of 14.5%.

Global PEGylated protein therapeutics market is expected to grow at a growing CAGR of 8.7% in the forecast period of 2019-2026. Increase in strategic alliances between the pharmaceuticals companies and growing adoption of PEGylated protein therapeutics are the key factors that fueling the market growth.

The active wound care or wound care biologics market accounted to USD 817.6 million in 2016 growing at a CAGR of 12.2% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Research projects that the Oral Proteins and Peptides market size will grow from XXX in 2019 to XXX by 2025, at an estimated CAGR of XX. The base year considered for the study is 2019, and the market size is projected from 2020 to 2025.

JSB Market Research published latest report titled "Global and USA Cancer Biomarker Market to 2018 (Identification, Technologies, Market Analysis, Competitor Profiles, Companion Diagnostic Co-Development, Business Strategies, Industry Trends, and Pipeline Analysis)" Browse complete report @ http://goo.gl/CYCwde

Type 2 Diabetes Mellitus (T2DM) is a metabolic disease characterized by chronic hyperglycemia (high blood glucose levels). Global prevalence has risen rapidly in the past several decades, particularly in line with obesity. This has been attributed to a range of factors, including economic development, increasing urbanization, aging populations, and changes in lifestyle patterns such as reduced levels of physical activity and consumption of higher-calorie diets. Enquiry @ http://www.researchbeam.com/type-2-diabetes-mellitus-therapeutics-in-major-developed-to-2021-strong-pipeline-and-expanding-treatment-population-to-encourage-robust-growth-market/enquire-about-report

Type 2 Diabetes Mellitus (T2DM) is a metabolic disease characterized by chronic hyperglycemia (high blood glucose levels). Global prevalence has risen rapidly in the past several decades, particularly in line with obesity.

Aptamers is an emerging market, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018. Aptamers existed in parallel with antibodies for two decades, but its market potential was not utilized, even to a fraction of antibodies. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.

$39.0 billion market for Type 2 Diabetes Mellitus Therapeutics in Major Developed industry to 2021. Browse the following link, for more information @ http://www.marketintelreports.com/report/gbihc366mr/type-2-diabetes-mellitus-therapeutics-in-major-developed-markets-to-2021--strong-pipeline-and-expanding-treatment-population-to-encourage-robust-growth

Big Market Research presents this report which estimates the market size for 2013 and provides a forecast until 2020, and covers disease epidemiology, treatment algorithms, and treatment use patterns. Read The Full Report @ http://www.bigmarketresearch.com/type-2-diabetes-theratype-2-diabetes-therapeutics-in-asia-pacific-to-2020-increasing-uptake-of-novel-drug-classes-to-drive-growthpeutics-in-asia-pacific-to-2020-increasing-uptake-of-novel-drug-classes-market

Type 2 Diabetes Mellitus (T2DM) is a metabolic disease characterized by chronic hyperglycemia (high blood glucose levels). Global prevalence has risen rapidly in the past several decades, particularly in line with obesity. This has been attributed to a range of factors, including economic development, increasing urbanization, aging populations, and changes in lifestyle patterns such as reduced levels of physical activity and consumption of higher-calorie diets.

The latest report by Precision Business Insights, titled “Sterile Injectable Contract Manufacturing Market” covers complete information on market size, share, growth, trends, segment analysis, key players, drivers, and restraints.

Get more information @ http://bit.ly/2kq4uSV Some of the key players in the diabetic retinopathy market include Bayer, Valeant Pharmaceutical, Novartis, F. Hoffmann-La Roche, Alimera Science, Abbott Laboratories, Pfizer, Regeneron Pharmaceutical, and Ampio Pharmaceuticals. Other notable players include Actavis, Boehringer Ingelheim, Kowa group, BCN peptides, ThromboGenics, Bausch & Lomb, iCo Therapeutics, Quark Pharmaceuticals and Vitreoretinal Technologies among others.

Bharat Book Bureau Provides the Trending Market Research Report; on “Global MicroRNA Research Markets Forecast to 2021”, (https://www.bharatbook.com/diagnostics-market-research-reports-946174/microrna-research-tools-diagnostics-therapeutics-global.html)The report provides magnified expenditure on study and development, demands for advanced technology, changes within the international socioeconomic situation and demand for novel, economical and cost–effective treatments.

According to our new research study on "Global Cosmeceuticals Market Forecast to 2028 – COVID-19 Impact and Analysis – by Active Ingredient, Distribution Channel, and Product" the cosmeceuticals market is expected to reach US$ 81.75 billion by 2028 from US$ 45.91 billion in 2021; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028. The report highlights trends prevailing in the market and factors governing its growth. The elevating demand for antiaging cosmeceuticals and increased adoption of online retail are fuelling the cosmeceuticals market growth. However, the adverse effects of the COVID-19 pandemic restrict the market growth.

TBRC global oral biologics and biosimilar drugs market report includes vaccines, proteins, peptides, monoclonal antibodies, others